drugset / Trial / NCT00698334
Efficacy of Thrice Weekly Directly Observed Treatment, Short-course (DOTS) in HIV-associated Tuberculosis
Phase 3
Completed
150 enrolled
All India Institute of Medical Sciences
Ministry of Health & Family Welfare, India · collab
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Tuberculosis (TB) is the most common opportunistic infection among HIV infected persons living in developing countries. Directly observed treatment, short-course (DOTS) is the internationally recommended strategy for the treatment of TB. However, the efficacy of DOTS for the treatment of HIV-associated TB is not well studied. This study aims to compare the efficacy of thrice weekly DOTS in HIV-infected versus HIV-negative patients with TB.
Timeline
- Start
- 2006-04
- Primary completion
- 2010-09
- Completion
- 2011-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ethambutol | Small molecule | 1200 mg | — |
| Comparator | INH | Unknown | 600 mg | — |
| Comparator | Pyrazinamide | Small molecule | 1500 mg | — |
| Comparator | Rifampin | Small molecule | 450 mg | — |
| Comparator | Rifampin | Small molecule | 600 mg | — |